Comparing Canadian and US opioid agonist therapy policies

Oregon Health & Science University and University of British Columbia findings include that, in Canada, opioid agonist therapy policy control shifted from federal to provincial authorities while US federal authorities maintain primary control of OAT regulations, and local OAT health insurance coverage policies were different.